339 related articles for article (PubMed ID: 30554211)
1. The REACH Trial: A Randomized Controlled Trial Assessing the Safety and Effectiveness of the Spiration® Valve System in the Treatment of Severe Emphysema.
Li S; Wang G; Wang C; Gao X; Jin F; Yang H; Han B; Zhou R; Chen C; Chen L; Bai C; Shen H; Herth FJF; Zhong N
Respiration; 2019; 97(5):416-427. PubMed ID: 30554211
[TBL] [Abstract][Full Text] [Related]
2. Sustained Clinical Benefits of Spiration Valve System in Patients with Severe Emphysema: 24-Month Follow-Up of EMPROVE.
Criner GJ; Mallea JM; Abu-Hijleh M; Sachdeva A; Kalhan R; Hergott CA; Lazarus DR; Mularski RA; Calero K; Reed MF; Nsiah-Dosu S; Himes D; Kubo H; Kinsey CM; Majid A; Hogarth DK; Kaplan PV; Case AH; Makani SS; Chen TM; Delage A; Zgoda M; Shepherd RW
Ann Am Thorac Soc; 2024 Feb; 21(2):251-260. PubMed ID: 37948704
[No Abstract] [Full Text] [Related]
3. Efficacy of the Spiration Valve System in Patients with Severe Heterogeneous Emphysema: A Systematic Review and Meta-Analysis.
Majid A; Labarca G; Uribe JP; Kheir F; Pacheco C; Folch E; Jantz MA; Mehta HJ; Patel NM; Herth FJF; Fernandez-Bussy S
Respiration; 2020; 99(1):62-72. PubMed ID: 31760389
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of the Spiration Valve System™ for the treatment of severe emphysema in patients with Alpha-1 antitrypsin deficiency (EMPROVE).
Hogarth DK; Delage A; Zgoda MA; Nsiah-Dosu S; Himes D; Reed MF
Respir Med; 2024 Apr; 224():107565. PubMed ID: 38364975
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of the 9-mm Intrabronchial Valve in Patients with Advanced Emphysema.
Kontogianni K; Gompelmann D; Valipour A; Gerovasili V; Schuhmann M; Stanzel F; Herth FJF; Eberhardt R
Respiration; 2020; 99(4):333-343. PubMed ID: 32311695
[TBL] [Abstract][Full Text] [Related]
6. A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM).
Kemp SV; Slebos DJ; Kirk A; Kornaszewska M; Carron K; Ek L; Broman G; Hillerdal G; Mal H; Pison C; Briault A; Downer N; Darwiche K; Rao J; Hübner RH; Ruwwe-Glosenkamp C; Trosini-Desert V; Eberhardt R; Herth FJ; Derom E; Malfait T; Shah PL; Garner JL; Ten Hacken NH; Fallouh H; Leroy S; Marquette CH;
Am J Respir Crit Care Med; 2017 Dec; 196(12):1535-1543. PubMed ID: 28885054
[TBL] [Abstract][Full Text] [Related]
7. Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial.
Criner GJ; Delage A; Voelker K; Hogarth DK; Majid A; Zgoda M; Lazarus DR; Casal R; Benzaquen SB; Holladay RC; Wellikoff A; Calero K; Rumbak MJ; Branca PR; Abu-Hijleh M; Mallea JM; Kalhan R; Sachdeva A; Kinsey CM; Lamb CR; Reed MF; Abouzgheib WB; Kaplan PV; Marrujo GX; Johnstone DW; Gasparri MG; Meade AA; Hergott CA; Reddy C; Mularski RA; Case AH; Makani SS; Shepherd RW; Chen B; Holt GE; Martel S
Am J Respir Crit Care Med; 2019 Dec; 200(11):1354-1362. PubMed ID: 31365298
[No Abstract] [Full Text] [Related]
8. Effect of Zephyr Endobronchial Valves on Dyspnea, Activity Levels, and Quality of Life at One Year. Results from a Randomized Clinical Trial.
Dransfield MT; Garner JL; Bhatt SP; Slebos DJ; Klooster K; Sciurba FC; Shah PL; Marchetti NT; Sue RD; Wright S; Rivas-Perez H; Wiese TA; Wahidi MM; Goulart de Oliveira H; Armstrong B; Radhakrishnan S; Shargill NS; Criner GJ;
Ann Am Thorac Soc; 2020 Jul; 17(7):829-838. PubMed ID: 32223724
[No Abstract] [Full Text] [Related]
9. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial.
Davey C; Zoumot Z; Jordan S; McNulty WH; Carr DH; Hind MD; Hansell DM; Rubens MB; Banya W; Polkey MI; Shah PL; Hopkinson NS
Lancet; 2015 Sep; 386(9998):1066-73. PubMed ID: 26116485
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of bronchoscopic lung volume reduction using unilateral endobronchial valve: a systematic review and meta-analysis.
Choi M; Lee WS; Lee M; Jeon K; Sheen S; Jheon S; Kim YS
Int J Chron Obstruct Pulmon Dis; 2015; 10():703-10. PubMed ID: 25848246
[TBL] [Abstract][Full Text] [Related]
11. A randomized study of endobronchial valves for advanced emphysema.
Sciurba FC; Ernst A; Herth FJ; Strange C; Criner GJ; Marquette CH; Kovitz KL; Chiacchierini RP; Goldin J; McLennan G;
N Engl J Med; 2010 Sep; 363(13):1233-44. PubMed ID: 20860505
[TBL] [Abstract][Full Text] [Related]
12. Current status of bronchoscopic lung volume reduction with endobronchial valves.
Shah PL; Herth FJ
Thorax; 2014 Mar; 69(3):280-6. PubMed ID: 24008689
[TBL] [Abstract][Full Text] [Related]
13. A multicenter trial of an intrabronchial valve for treatment of severe emphysema.
Wood DE; McKenna RJ; Yusen RD; Sterman DH; Ost DE; Springmeyer SC; Gonzalez HX; Mulligan MS; Gildea T; Houck WV; Machuzak M; Mehta AC
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):65-73. PubMed ID: 17198782
[TBL] [Abstract][Full Text] [Related]
14. Effect of Endobronchial Coils vs Usual Care on Exercise Tolerance in Patients With Severe Emphysema: The RENEW Randomized Clinical Trial.
Sciurba FC; Criner GJ; Strange C; Shah PL; Michaud G; Connolly TA; Deslée G; Tillis WP; Delage A; Marquette CH; Krishna G; Kalhan R; Ferguson JS; Jantz M; Maldonado F; McKenna R; Majid A; Rai N; Gay S; Dransfield MT; Angel L; Maxfield R; Herth FJ; Wahidi MM; Mehta A; Slebos DJ;
JAMA; 2016 May 24-31; 315(20):2178-89. PubMed ID: 27179849
[TBL] [Abstract][Full Text] [Related]
15. Protocol of a Randomized Controlled Study of the PneumRx Endobronchial Coil System versus Standard-of-Care Medical Management in the Treatment of Subjects with Severe Emphysema (ELEVATE).
Herth FJF; Slebos DJ; Shah PL; Hetzel M; Schmid-Bindert G; LaPrad AS; Deslée G; Valipour A
Respiration; 2019; 98(6):512-520. PubMed ID: 31743933
[TBL] [Abstract][Full Text] [Related]
16. Baseline regional perfusion impacts exercise response to endobronchial valve therapy in advanced pulmonary emphysema.
Argula RG; Strange C; Ramakrishnan V; Goldin J
Chest; 2013 Nov; 144(5):1578-1586. PubMed ID: 23828481
[TBL] [Abstract][Full Text] [Related]
17. Endobronchial Valve (Zephyr) Treatment in Homogeneous Emphysema: One-Year Results from the IMPACT Randomized Clinical Trial.
Eberhardt R; Slebos DJ; Herth FJF; Darwiche K; Wagner M; Ficker JH; Petermann C; Hübner RH; Stanzel F; Shargill NS; Valipour A;
Respiration; 2021; 100(12):1174-1185. PubMed ID: 34350884
[TBL] [Abstract][Full Text] [Related]
18. Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial.
Herth FJ; Valipour A; Shah PL; Eberhardt R; Grah C; Egan J; Ficker JH; Wagner M; Witt C; Liebers U; Hopkins P; Gesierich W; Phillips M; Stanzel F; McNulty WH; Petermann C; Snell G; Gompelmann D
Lancet Respir Med; 2016 Mar; 4(3):185-93. PubMed ID: 26899390
[TBL] [Abstract][Full Text] [Related]
19. Endobronchial Valve Treatment in Emphysema Patients with a Very Low DLCO.
van Dijk M; Hartman JE; Klooster K; Ten Hacken NHT; Kerstjens HAM; Slebos DJ
Respiration; 2020; 99(2):163-170. PubMed ID: 31962325
[TBL] [Abstract][Full Text] [Related]
20. An update on the efficacy of endobronchial valve therapy in the management of hyperinflation in patients with chronic obstructive pulmonary disease.
Valipour A; Burghuber OC
Ther Adv Respir Dis; 2015 Dec; 9(6):294-301. PubMed ID: 26294417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
